I am pleased to share with you our latest work from the Laboratory of Molecular Immunology and Immunopathology at Sapienza University of Rome, Italy, on Pol I inhibition, nucleolar stress response, and NK-cell recognition and killing of #myeloma cells. https://t.co/ty3C70Ns0Q
Immunomodulatory effect of #NEDD8-activating enzyme inhibition in Multiple #Myeloma: upregulation of #NKG2D ligands and sensitization to Natural Killer cell recognition. https://t.co/zbSajpwpWk
Role of Aiolos and Ikaros in the Antitumor and Immunomodulatory Activity of IMiDs in Multiple Myeloma: Better to Lose Than to Find Them https://t.co/Ny01V61nOt #mdpiijms#myeloma#cancer#oncology via @IJMS_MDPI
#mdpicancers#genotoxic The POU-Domain Transcription Factor Oct-6/POU3F1 as a Regulator of Cellular Response to Genotoxic Stress https://t.co/ZPIqTgfKtO @Cancers_MDPI
"The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors" Our latest is now available. https://t.co/LBMlqa5Nr8 #myeloma
"Activation of liver X receptor up-regulates the expression of the NKG2D ligands MICA and MICB in multiple myeloma through different molecular mechanisms." Our latest is now available @FASEBJournal https://t.co/mJURI8iw6y #myeloma